About Unistar Biotech
Unistar Biotech is a Healthcare company based in Delhi (India) founded in 2010. Develops, manufactures, and distributes pharmaceutical products for healthcare therapeutic needs globally. It operates on a B2B and D2C model. Its Indian entity Unistar Biotech Limited reported revenue of ₹25.06 Cr. Unistar Biotech offers products and services including Psychiatry Products, Antibiotics, Neuropsychiatry Products, Gastroenterology Products, and Orthopaedics Products. Its focus areas include Pharmaceuticals, Therapeutic Segments, Specialty Medicines and Biopharmaceuticals.
Company details
Unistar Biotech Limited is a pharmaceutical company focused on developing and marketing high-quality medicines for therapeutic segments including psychiatry, neuropsychiatry, gastroenterology, antibiotics, orthopaedics, gynaecology, and dentistry. It operates through research, manufacturing, and distribution processes to provide affordable healthcare solutions. Based in Delhi, India, the company emphasizes ethical practices and innovation to serve global markets and improve patient lives.
- Headquarters Delhi, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ubl.co.in
- Legal Name Unistar Biotech Limited
- Date of Incorporation 06 Dec, 2010
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹25.06 Cr
FY 2025 · +57% YoY
- Net Profit₹49.2 Lakh
FY 2025 · 2% margin
- EBITDA₹97.4 Lakh
FY 2025 · 4% margin
Associated legal entities of Unistar Biotech
Unistar Biotech operates through Unistar Biotech Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Unistar Biotech Limited CIN U24230GJ2010PLC063156 | Active | 06 Dec 2010 | Ahmedabad, Gujarat | ₹25.1 Cr | 121 | 7 | View details |
Products & Services of Unistar Biotech
Unistar Biotech offers a comprehensive portfolio of products and services, including Psychiatry Products, Antibiotics, Neuropsychiatry Products, Gastroenterology Products, and Orthopaedics Products.
Medications for treating mental health disorders and conditions.
Drugs designed to combat bacterial infections effectively.
Treatments for neurological and psychiatric disorders.
Medications for digestive system health issues.
Solutions for bone and joint-related treatments.
Board of directors of Unistar Biotech Limited (Unistar Biotech)
Unistar Biotech Limited is the primary company behind Unistar Biotech. The board of Unistar Biotech Limited currently have 7 directors; the longest-serving is Sanjay Kumar, appointed in 2010. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjay Kumar DIN 02151189 | Director | 06 Dec 2010 | 15 yrs 11 mo | Unistar Biotech Limited |
| Yogendra Kumar DIN 02178033 | Director | 06 Dec 2010 | 15 yrs 11 mo | Unistar Biotech Limited |
| Aseem Kumar DIN 02212639 | Director | 06 Dec 2010 | 15 yrs 11 mo | Unistar Biotech Limited |
| Prakash Chandra DIN 02748304 | Director | 04 May 2012 | 14 yrs 6 mo | Unistar Biotech Limited |
| Manish Kumar DIN 02303002 | Director | 04 May 2012 | 14 yrs 6 mo | Unistar Biotech Limited |
| Randhir Singh DIN 05254044 | Director | 04 May 2012 | 14 yrs 6 mo | Unistar Biotech Limited |
| Ashutosh Kumar Saxena DIN 03417112 | Director | 30 Sep 2019 | 7 yrs 1 mo | Unistar Biotech Limited |
Financials of Unistar Biotech
Figures of Unistar Biotech Limited, the primary company behind Unistar Biotech, for FY 2025. Revenue was ₹25.06 Cr (+57% year on year). Net profit was ₹49.2 Lakh (2% margin). EBITDA was ₹97.4 Lakh (4% margin). Revenue has grown at a compounded annual rate of +34% over three years and +18% over five years.
- ₹25.06 CrRevenue · FY 2025 · +57% YoY
- ₹49.2 LakhNet profit · 2% margin
- ₹97.4 LakhEBITDA · 4% margin
- ₹1.00 CrPaid-up capital
- 121Employees (provident fund records)
- +34%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Unistar Biotech Limited are on its company page.
Detailed financial statements for Unistar Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Unistar Biotech
Unistar Biotech was founded in 2010.
Unistar Biotech is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Unistar Biotech, Unistar Biotech Limited, reported revenue of ₹25.06 Cr for FY 2025, up 57% year on year.
Unistar Biotech Limited is a pharmaceutical company focused on developing and marketing high-quality medicines for therapeutic segments including psychiatry, neuropsychiatry, gastroenterology, antibiotics, orthopaedics, gynaecology, and dentistry. It operates through research, manufacturing, and distribution processes to provide affordable healthcare solutions. Based in Delhi, India, the company emphasizes ethical practices and innovation to serve global markets and improve patient lives.
Unistar Biotech offers Psychiatry Products, Antibiotics, Neuropsychiatry Products, Gastroenterology Products, and Orthopaedics Products.
Unistar Biotech operates through Unistar Biotech Limited.
The legal entities of Unistar Biotech currently have 7 directors, including Sanjay Kumar, Yogendra Kumar, Ashutosh Kumar Saxena and others.